BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3

• Press Releases

  Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 2, 2026

  September 2, 2026

   · 

  1 min read
• Press Releases

  Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC

  September 2, 2026

   · 

  5 min read
• Press Releases

  Novavax to Participate in September 2026 Investor Conferences

  September 2, 2026

   · 

  1 min read
• Press Releases

  Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences

  September 2, 2026

   · 

  1 min read
• Press Releases

  New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

  September 2, 2026

   · 

  11 min read
• Press Releases

  Ivonescimab Monotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in HARMONi-2 Study Conducted by Akeso in China

  September 2, 2026

   · 

  12 min read